Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Oncology/Hematology Market Research

NA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 194 Pages Data Bridge Market Research January, 2023 DAABD17746972
Best Price Guarantee
Price from $3,500
Length 194 Pages
Publisher Data Bridge Market Research
Published Date January, 2023
SKU DAABD17746972

NA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030

North America Breast Cancer Diagnostics Market, By Test Type (Imaging, Biopsy, Genomic Test, Blood Test, and Others), Type (Ductal In Situ Carcinoma, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030.

Market Definition

Breast cancer is a disease in which the uncontrolled growth of malignant cells in the breast tissue occurs more often in women than in men. Breast cancer is the uncontrolled cell division of breast cells, which are the most common cells in the mammary glands and ducts. Some symptoms of breast cancer include a lump or lump in the breast, bloody discharge from the nipple and a change in the shape of the nipple or breast. Breast cancer treatment depends on the stage of cancer. Its treatment consists of chemotherapy, radiation therapy, hormone therapy, and surgery.

Breast cancer is another type of cancer that is more common in women than in men. A number of the symptoms of the sickness hold bleeding secretion from the reproductive organ, a lump or block within the breast, and variations in the texture or form of the breast or nipple. Breast cancer treatment depends on the stage of cancer. In addition, its treatment includes radiotherapy, therapy, hormone therapy and surgery. Early detection of carcinoma is essential for the effective treatment of the disease. Early detection of the disease also leads to better outcomes, including many treatment options, better survival and better quality of life. Increasing pressure and demand for new forms of treatment or methods of treatment are due to the rapidly increasing spread of diseases.

Market Segmentation

The North America breast cancer diagnostic market is segmented into four notable segments which are based on test type, type, end user, and distribution channel.
• On the basis of test type, the North America breast cancer diagnostic market is segmented into imaging, biopsy, genomic test, blood tests and others
• On the basis of type, the North America breast cancer diagnostic market is segmented into ductal in situ carcinoma, invasive ductal carcinoma, inflammatory breast cancer, and metastatic breast cancer
• On the basis of end user, the North America breast cancer diagnostic market is segmented into hospitals, clinics, research and academic institutes, diagnostic centers and others
• On the basis of distribution channel, the North America breast cancer diagnostic market is segmented into direct tender, retail sales and others

Market Players

Some of the major players operating in the North America breast cancer diagnostic market are:
• F-Hoffmann La Roche Ltd.
• Siemens Healthcare GmbH
• General Electric
• Exact Sciences Corporation
• Biocept, Inc.
• Abacus ALS


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Breast Cancer Diagnostic Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market End User Coverage Grid
2.8 Test Type Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter's 5 Forces
5 Epidemiology
6 Industrial Insights
7 Regulatory Framework
8 Market Overview
8.1 Drivers
8.1.1 Launch Of Technologically Advanced Diagnosis & Therapeutics To Aid Growth
8.1.2 Increasing Prevalence Of Breast Cancer
8.1.3 Growing Importance Of Women's Health
8.1.4 Rising Awareness Towards The Breast Cancer
8.2 Restraints
8.2.1 Adverse Effects Of Breast Cancer Therapeutics
8.2.2 High Cost Of The Imaging Systems
8.3 Opportunities
8.3.1 Initiatives Taken By The Government
8.3.2 Strategic Initiatives Taken By The Key Market Players
8.3.3 Growth In Research And Development Of Breast Cancer
8.4 Challenges
8.4.1 Lack Of Diagnostic Infrastructure
8.4.2 Lack Of Skilled Professionals For Proper Diagnosis Of Breast Cancer
9 North America Breast Cancer Diagnostics Market, By Test Type
9.1 Overview
9.2 Imaging
9.2.1 Ionizing Breast Imaging Technologies
9.2.1.1 Full-field Digital Mammography (Ffdm)
9.2.1.2 Analog Mammography
9.2.1.3 3d Breast Tomosynthesis
9.2.1.4 Positron Emission Tomography/ Computed Tomography (Pet/Ct)
9.2.1.5 Molecular Breast Imaging/ Breast Specific Gamma Imaging (Mbi/Bsmi)
9.2.1.6 Positron Emission Mammography
9.2.1.7 Others
9.2.2 Non-ionizing Imaging Technologies
9.2.2.1 Optical Imaging
9.2.2.2 Breast Ultrasound
9.2.2.3 Breast Mri (Magnetic Resonance Imaging)
9.2.2.4 Automated Whole Breast Ultrasound (Awbu)
9.2.2.5 Breast Thermography
9.2.3 Biopsy
9.2.3.1 Surgical Biopsy
9.2.3.2 Fine Needle Aspiration Biopsy
9.2.3.3 Core Needle Biopsy
9.2.3.4 Image-guided Biopsy
9.2.3.5 Sentinel Lymph Node Biopsy
9.2.4 Genomic Test
9.2.4.1 Molecular Testing
9.2.4.1.1 Pd-l1
9.2.4.1.2 Microsatellite Instability-high (Msi-h) Or Dna Mismatch Repair Deficiency (Dmmr)
9.2.4.1.3 Ntrk Gene Fusions
9.2.4.1.4 Pi3kca Gene Mutation
9.2.4.2 Mammaprint
9.2.4.3 Oncotype Dx
9.2.4.4 Others
9.3 Blood Test
9.4 Others
10 North America Breast Cancer Diagnostics Market, By Type
10.1 Overview
10.2 Invasive Ductal Carcinoma
10.3 Ductal Carcinoma In Situ
10.4 Inflammatory Breast Cancer
10.5 Metastatic Breast Cancer
11 North America Breast Cancer Diagnostics Market, By End User
11.1 Overview
11.2 Hospitals
11.3 Diagnostics Centers
11.4 Clinics
11.5 Research & Academic Institutes
11.6 Others
12 North America Breast Cancer Diagnostics Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
12.4 Others
13 North America Breast Cancer Diagnostics Market, By Region
13.1 North America
13.1.1 U.S.
13.1.2 Canada
13.1.3 Mexico
14 North America Breast Cancer Diagnostics Market, Company Landscape
14.1 Company Share Analysis: North America
15 Swot Analysis
16 Company Profile
16.1 Hologic, Inc.
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Siemens Healthcare Gmbh
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 F. Hoffmann- La Roche Ltd
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 Koninklijke Philips N.V.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Abbott
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Developments
16.6 Abacus Als
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Developments
16.7 Bd
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Company Share Analysis
16.7.4 Product Portfolio
16.7.5 Recent Developments
16.8 Biocept, Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Biomérieux
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Developments
16.10 Bio-rad Laboratories, Inc.
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
16.11 Cepheid
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Development
16.12 Exact Sciences Corporation
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Company Share Analysis
16.12.4 Product Portfolio
16.12.5 Recent Developments
16.13 Fujifilm Corporation
16.13.1 Company Snapshot
16.13.2 Revenue Analysis
16.13.3 Product Portfolio
16.13.4 Recent Development
16.14 General Electric
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Developments
16.15 Illumina, Inc.
16.15.1 Company Snapshot
16.15.2 Revenue Analysis
16.15.3 Product Portfolio
16.15.4 Recent Developments
16.16 Myriad Genetics, Inc.
16.16.1 Company Snapshot
16.16.2 Revenue Analysis
16.16.3 Product Portfolio
16.16.4 Recent Development
16.17 Nanostring.
16.17.1 Company Snapshot
16.17.2 Revenue Analysis
16.17.3 Product Portfolio
16.17.4 Recent Development
16.17.5 Recent Development
16.18 Oncostem.
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
16.19 Provista Diagnostics.
16.19.1 Company Snapshot
16.19.2 Product Portfolio
16.19.3 Recent Development
16.20 Thermo Fisher Scientific Inc.
16.20.1 Company Snapshot
16.20.2 Revenue Analysis
16.20.3 Product Portfolio
16.20.4 Recent Development
17 Questionnaire
18 Related Reports 194
List Of Tables
Table 1 Incidence Rate Of Breast Cancer (2020)
Table 2 Mortality Rate Of Breast Cancer (2020)
Table 3 Incidence Of Ductal Carcinoma In Situ (Dcis) Breast Cancer
Table 4 North America Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 5 North America Imaging In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 6 North America Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 7 North America Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 8 North America Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 9 North America Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 10 North America Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 11 North America Biopsy In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 12 North America Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 13 North America Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 14 North America Genomic Test In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 15 North America Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 16 North America Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 17 North America Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 18 North America Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 19 North America Blood Test In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 20 North America Others In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 21 North America Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 22 North America Invasive Ductal Carcinoma In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 North America Ductal Carcinoma In Situ In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 24 North America Inflammatory Breast Cancer In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 25 North America Metastatic Breast Cancer In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 North America Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 27 North America Hospitals In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 28 North America Diagnostic Centers In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 29 North America Clinics In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 30 North America Research And Academic Institutes In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 31 North America Others In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 32 North America Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 33 North America Direct Tender In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 34 North America Retail Sales In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 35 North America Others In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 36 North America Breast Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 37 North America Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 38 North America Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 39 North America Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 40 North America Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 41 North America Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 42 North America Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 43 North America Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 44 North America Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 45 North America Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 46 North America Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 47 North America Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 48 North America Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 49 North America Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 50 North America Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 51 North America Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 52 U.S. Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 53 U.S. Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 54 U.S. Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 55 U.S. Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 56 U.S. Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 57 U.S. Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 58 U.S. Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 59 U.S. Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 60 U.S. Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 61 U.S. Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 62 U.S. Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 63 U.S. Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 64 U.S. Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 65 U.S. Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 66 U.S. Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 67 U.S. Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 68 U.S. Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 69 U.S. Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 70 U.S. Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 71 U.S. Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 72 Canada Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 73 Canada Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 74 Canada Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 75 Canada Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 76 Canada Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 77 Canada Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 78 Canada Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 79 Canada Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 80 Canada Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 81 Canada Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 82 Canada Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 83 Canada Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 84 Canada Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 85 Canada Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 86 Canada Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 87 Canada Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 88 Canada Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 89 Canada Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 90 Canada Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 91 Canada Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 92 Mexico Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 93 Mexico Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 94 Mexico Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 95 Mexico Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 96 Mexico Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 97 Mexico Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 98 Mexico Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 99 Mexico Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 100 Mexico Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 101 Mexico Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 102 Mexico Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 103 Mexico Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 104 Mexico Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 105 Mexico Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 106 Mexico Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 107 Mexico Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 108 Mexico Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 109 Mexico Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 110 Mexico Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 111 Mexico Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million) 116
List Of Figures
Figure 1 North America Breast Cancer Diagnostic Market: Segmentation
Figure 2 North America Breast Cancer Diagnostic Market: Data Triangulation
Figure 3 North America Breast Cancer Diagnostic Market: Droc Analysis
Figure 4 North America Breast Cancer Diagnostic Market: North America Vs Regional Market Analysis
Figure 5 North America Breast Cancer Diagnostic Market: Company Research Analysis
Figure 6 North America Breast Cancer Diagnostic Market: Interview Demographics
Figure 7 North America Breast Cancer Diagnostic Market: Market End User Coverage Grid
Figure 8 North America Breast Cancer Diagnostic Market: Dbmr Market Position Grid
Figure 9 North America Breast Cancer Diagnostic Market: Vendor Share Analysis
Figure 10 North America Breast Cancer Diagnostic Market: Segmentation
Figure 11 Growing Awareness Of Breast Cancer And Increasing Healthcare Expenditure Is Expected To Drive The Growth Of The North America Breast Cancer Diagnostic Market From 2023 To 2030
Figure 12 The Imaging Segment Is Expected To Account For The Largest Share Of The North America Breast Cancer Diagnostic Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Breast Cancer Diagnostics Market
Figure 14 North America Breast Cancer Diagnostics Market : By Test Type, 2022
Figure 15 North America Breast Cancer Diagnostics Market : By Test Type, 2023-2030 (Usd Million)
Figure 16 North America Breast Cancer Diagnostics Market : By Test Type, Cagr (2023-2030)
Figure 17 North America Breast Cancer Diagnostics Market : By Test Type, Lifeline Curve
Figure 18 North America Breast Cancer Diagnostics Market : By Type, 2022
Figure 19 North America Breast Cancer Diagnostics Market : By Type, 2023-2030 (Usd Million)
Figure 20 North America Breast Cancer Diagnostics Market : By Type, Cagr (2023-2030)
Figure 21 North America Breast Cancer Diagnostics Market : By Type, Lifeline Curve
Figure 22 North America Breast Cancer Diagnostics Market : By End User, 2022
Figure 23 North America Breast Cancer Diagnostics Market : By End User, 2023-2030 (Usd Million)
Figure 24 North America Breast Cancer Diagnostics Market : By End User, Cagr (2023-2030)
Figure 25 North America Breast Cancer Diagnostics Market : By End User, Lifeline Curve
Figure 26 North America Breast Cancer Diagnostics Market : By Distribution Channel, 2022
Figure 27 North America Breast Cancer Diagnostics Market : By Distribution Channel, 2023-2030 (Usd Million)
Figure 28 North America Breast Cancer Diagnostics Market : By Distribution Channel, Cagr (2023-2030)
Figure 29 North America Breast Cancer Diagnostics Market : By Distribution Channel, Lifeline Curve
Figure 30 North America Breast Cancer Diagnostics Market: Snapshot (2022)
Figure 31 North America Breast Cancer Diagnostics Market: By Country (2022)
Figure 32 North America Breast Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 33 North America Breast Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 34 North America Breast Cancer Diagnostics Market: Test Type (2023-2030)
Figure 35 North America Breast Cancer Diagnostics Market: Company Share 2022 (%) 116

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings